EGFR EXON 20 INSERTION MUTATION
Clinical trials for EGFR EXON 20 INSERTION MUTATION explained in plain language.
Never miss a new study
Get alerted when new EGFR EXON 20 INSERTION MUTATION trials appear
Sign up with your email to follow new studies for EGFR EXON 20 INSERTION MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists probe resistance to targeted lung cancer drug
Knowledge-focused Recruiting nowThis study looks at why some lung cancers with a specific gene change (EGFR exon 20 insertion) stop responding to the drug amivantamab. Researchers will collect blood and tumor samples from 30 patients when their disease gets worse. The goal is to find the genetic changes that ca…
Matched conditions: EGFR EXON 20 INSERTION MUTATION
Phase: NA • Sponsor: Groupe Francais De Pneumo-Cancerologie • Aim: Knowledge-focused
Last updated May 17, 2026 00:30 UTC
-
Lung cancer combo under the microscope: how does it really perform?
Knowledge-focused Recruiting nowThis study watches 100 adults with a certain type of advanced lung cancer who are already receiving a drug combo (amivantamab plus chemo) through an early access program. Researchers want to see how long the treatment keeps the cancer from growing in everyday medical practice. No…
Matched conditions: EGFR EXON 20 INSERTION MUTATION
Sponsor: GFPC Investigation • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC